NOVEL APPROACH FOR THE PREVENTION OF RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS FROM ONGOING PHASE III TRIAL WITH CIVACIR (R)

NOVEL APPROACH FOR THE PREVENTION OF RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS FROM ONGOING PHASE III TRIAL WITH CIVACIR (R) Article

Full Text via DOI: 10.1016/S0168-8278(15)30171-9 Web of Science: 000361967600171

Terrault, N.; Shrestha, R.; Satapathy, S. K.; O'Leary, J. G.; Campsen, J.; Rosenau, J.; Spivey, J.; Teperman, L. W.; Therapondos, G.; Verna, E. C.; Vierling, J. M.; Schiano, T. D.; Sher, L.; Khallafi, H.; Victor, D.; Bhamidimarri, K. R.; Gordon, F. D.; Hanish, S.; Kulik, L. M.; Lake-Bakaar, G.; Maluf, D.; Porayko, M.; Bramer, S. L.; Osgood, G.; Chavan, S.; Daelken, N.